APRA Formalizes Capital Treatment and Reporting of COVID-19 Loans

Earlier, in August 2020, APRA had proposed to give effect to the temporary capital treatment of loans with repayment deferrals or restructuring due to COVID-19 by way of adjustments to APS 220. APRA had also proposed to promote public transparency by collecting and publishing entity-level data on loans impacted by COVID-19, through a new reporting standard ARS 923.2. APRA has received seven submissions in response to its consultation—all of which APRA has published. Respondents broadly supported the proposal to adjust APS 220 but sought clarification on the scope of loans eligible for the temporary capital treatment. Respondents also requested flexibility in the application of the temporary measures, particularly the treatment of restructuring and counting of arrears. In response to the request for additional flexibility for restructuring, APRA has removed the requirement under paragraph 8 of Attachment E to APS 220, which states that loans may only be restructured once. In relation to the counting of arrears, paragraph 7 has been amended to clarify that an authorized deposit-taking institution may reset the arrears count to zero where it modifies the loan to adjust for the deferral period and any existing arrears. 

Additionally, respondents generally supported the proposal to collect and publish entity-level data on COVID-19 impacted loans through a new Reporting Standard, ARS 923.2. The key area of focus in submissions was reducing the reporting burden on industry, particularly for smaller authorized deposit-taking institutions. Respondents suggested that APRA should consider extending the reporting timeframe and reduce duplication with other data requests. Respondents also sought more clarity on specific data reporting items and the expectations for additional self-disclosures. To help reduce the reporting burden for smaller authorized deposit-taking institutions, APRA is:

• Increasing the publication threshold from AUD 10 million in total loans subject to repayment deferral to AUD 20 million. Where authorized deposit-taking institutions fall below the AUD 20 million threshold, they will be asked, from September, to provide ARF 923.2 on a quarterly rather than a monthly basis.
• Clarifying that, for non-listed authorized deposit-taking institutions, its expectations of public disclosures on loan repayment deferrals will be met by way of the APRA publication. APRA expects that listed authorized deposit-taking institutions will make additional information publicly available.
• Continuing to review and engage with industry on additional ways in which APRA can minimize the reporting burden during the COVID-19 period. This includes the recent extension of the due date from 10 to 15 business days for authorized deposit-taking institutions to report data on ARF 923.0 on credit and capital and the temporary pausing and review of ARF 923.1 on provisioning.

APRA is, however, maintaining the requirement for authorized deposit-taking institutions to report data on ARF 923.2 within 10 business days after the end of the reporting period to which the information relates. In response to the industry concerns over reporting duplication, APRA clarified that the data used for the entity-level publication will be taken from the existing ARF 923.2 returns. 

Related Links

• Press Release
• Letter
• APS 220
• ARS 923.2
• Overview of Consultation

Effective Date: September 09, 2020

Keywords: Asia Pacific, Australia, Banking, COVID-19, Credit Risk, Loan Moratorium, Regulatory Capital, Reporting, Basel, APS 220, ARS 923.2, Payment Deferrals, APRA